{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:18:12Z","timestamp":1791105492228,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA108975"],"award-info":[{"award-number":["R01CA108975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES-010016-14"],"award-info":[{"award-number":["ES-010016-14"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bcp.2012.11.025","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T21:36:32Z","timestamp":1354829792000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Xingya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Joon","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Eling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.11.025_bib0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(24)09260-5","article-title":"Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities","volume":"59","author":"Baek","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0010","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.11.025_bib0015","doi-asserted-by":"crossref","first-page":"20127","DOI":"10.1074\/jbc.M909580199","article-title":"Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression","volume":"275","author":"Li","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0020","doi-asserted-by":"crossref","first-page":"13760","DOI":"10.1074\/jbc.273.22.13760","article-title":"Cloning and characterization of a novel member of the transforming growth factor-beta\/bone morphogenetic protein family","volume":"273","author":"Paralkar","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","article-title":"Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1)","volume":"237","author":"Bottner","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2012.11.025_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","article-title":"PLAB, a novel placental bone morphogenetic protein","volume":"1354","author":"Hromas","year":"1997","journal-title":"Biochim Biophys ACTA"},{"key":"10.1016\/j.bcp.2012.11.025_bib0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","article-title":"Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta","volume":"203","author":"Lawton","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2012.11.025_bib0045","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/emboj\/19.10.2212","article-title":"The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-{beta} superfamily member, acts as a quality control determinant for correctly folded MIC-1","volume":"19","author":"Bauskin","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2012.11.025_bib0050","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1158\/0008-5472.CAN-04-3827","article-title":"The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome","volume":"65","author":"Bauskin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/pros.21471","article-title":"The H6D variant of NAG-1\/GDF15 inhibits prostate xenograft growth in vivo","volume":"72","author":"Wang","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2012.11.025_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1073\/pnas.97.1.109","article-title":"PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway","volume":"97","author":"Tan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.11.025_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5483\/BMBRep.2010.43.2.091","article-title":"Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells","volume":"43","author":"Park","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.bcp.2012.11.025_bib0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgn031","article-title":"Macrophage inhibitory cytokine-1 activates AKT and ERK-1\/2 via the transactivation of ErbB2 in human breast and gastric cancer cells","volume":"29","author":"Kim","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0075","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","article-title":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury","volume":"20","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0080","doi-asserted-by":"crossref","first-page":"33384","DOI":"10.1074\/jbc.M101814200","article-title":"Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3","volume":"276","author":"Baek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tvjl.2006.12.001","article-title":"Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1)","volume":"175","author":"Yamaguchi","year":"2008","journal-title":"Vet J"},{"key":"10.1016\/j.bcp.2012.11.025_bib0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.301.3.1126","article-title":"Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene","volume":"301","author":"Baek","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/carcin\/23.3.425","article-title":"Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53","volume":"23","author":"Baek","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ijc.11173","article-title":"Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells","volume":"105","author":"Wilson","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jn\/132.4.773","article-title":"Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells","volume":"132","author":"Bottone","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2012.11.025_bib0110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/carcin\/bgi268","article-title":"Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner","volume":"27","author":"Lee","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0115","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/carcin\/bgh255","article-title":"Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells","volume":"25","author":"Baek","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0120","unstructured":"Kang SU, Lee B-S, Lee S-H, Baek SJ, Shin YS, Kim C-H. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J Nutr Biochem; in press."},{"key":"10.1016\/j.bcp.2012.11.025_bib0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2004.12.138","article-title":"Indole-3-carbinol and 3,3\u2032-diindolylmethane induce expression of NAG-1 in a p53-independent manner","volume":"328","author":"Lee","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.11.025_bib0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jnutbio.2011.03.009","article-title":"Capsaicin represses transcriptional activity of beta-catenin in human colorectal cancer cells","volume":"23","author":"Lee","year":"2012","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jnutbio.2011.04.017","article-title":"Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells","volume":"23","author":"Nualsanit","year":"2012","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0140","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1074\/jbc.M208394200","article-title":"Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity","volume":"278","author":"Baek","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1158\/1535-7163.MCT-05-0528","article-title":"A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells","volume":"5","author":"Yamaguchi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0150","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1124\/mol.105.017046","volume":"68","author":"Chintharlapalli","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2407-11-146","article-title":"Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells","volume":"11","author":"Chiu","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1124\/mol.63.3.557","article-title":"Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids","volume":"63","author":"Newman","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-007-9648-y","article-title":"1,1-Bis(3\u2032-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways","volume":"109","author":"Vanderlaag","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2012.11.025_bib0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.104.005108","article-title":"Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein","volume":"67","author":"Baek","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/toxsci\/kfh272","article-title":"EGR1 is a novel target for AhR agonists in human lung epithelial cells","volume":"82","author":"Martinez","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bcp.2012.11.025_bib0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/carcin\/bgq016","article-title":"NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C\/EBPbeta and ATF3","volume":"31","author":"Lee","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0185","doi-asserted-by":"crossref","first-page":"33129","DOI":"10.1074\/jbc.M805248200","article-title":"Nonsteroidal anti-inflammatory drug-activated gene (NAG-1\/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A","volume":"283","author":"Yoshioka","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.26082","article-title":"DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1\/GDF15) in glioma cell lines","volume":"130","author":"Kadowaki","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0195","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/jpet.105.100081","article-title":"Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene\/macrophage inhibitory cytokine-1\/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth","volume":"318","author":"Martinez","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0200","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jcp.20692","article-title":"Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth","volume":"208","author":"Lambert","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0205","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1038\/sj.onc.1205610","article-title":"Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1","volume":"21","author":"Albertoni","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.11.025_bib0210","first-page":"649","article-title":"NSAID activated gene (NAG-1), a modulator of tumorigenesis","volume":"39","author":"Eling","year":"2006","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0215","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia","volume":"131","author":"Baek","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2012.11.025_bib0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1940-6207.CAPR-09-0057","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice","volume":"2","author":"Cekanova","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bcp.2012.11.025_bib0225","doi-asserted-by":"crossref","first-page":"e43833","DOI":"10.1371\/journal.pone.0043833","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice","volume":"7","author":"Husaini","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2012.11.025_bib0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00432-009-0691-4","article-title":"Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin\/+mouse model of intestinal cancer","volume":"136","author":"Zimmers","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/jid.2008.270","article-title":"Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity","volume":"129","author":"Boyle","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0240","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/onc.2009.420","article-title":"Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway","volume":"29","author":"Senapati","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.11.025_bib0245","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0006-291X(03)00823-4","article-title":"Dysregulated expression of MIC-1\/PDF in human prostate tumor cells","volume":"305","author":"Karan","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2012.11.025_bib0250","first-page":"4648","article-title":"Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system","volume":"63","author":"Lee","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0255","first-page":"2642","article-title":"MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma","volume":"9","author":"Brown","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-11-0786","article-title":"Serum macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a potential screening tool for the prevention of colon cancer?","volume":"21","author":"Brown","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2012.11.025_bib0265","unstructured":"Ko JK, Auyeung KK. Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation. Curr Pharm Des; in press."},{"key":"10.1016\/j.bcp.2012.11.025_bib0270","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/mnfr.201100651","article-title":"2\u2032-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells","volume":"56","author":"Shin","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0275","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.ejca.2010.07.007","article-title":"Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53","volume":"46","author":"Zhong","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0280","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2010.03.008","article-title":"Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells","volume":"80","author":"Thapa","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0285","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1074\/jbc.M111.330639","article-title":"Two in-and-out modulation strategies for endoplasmic reticulum stress-linked gene expression of pro-apoptotic macrophage-inhibitory cytokine 1","volume":"287","author":"Park","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.11.025_bib0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrgastro.2009.44","article-title":"Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer","volume":"6","author":"Feagins","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0295","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4161\/cbt.5.5.2602","article-title":"Induction of GDF-15\/NAG-1\/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis","volume":"5","author":"Kadara","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0300","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.107.126193","article-title":"Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells","volume":"323","author":"Chen","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0305","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.bcp.2008.02.002","article-title":"Implication of NAG-1 in synergistic induction of apoptosis by combined treatment of sodium salicylate and PI3K\/MEK1\/2 inhibitors in A549 human lung adenocarcinoma cells","volume":"75","author":"Kim","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)64717-7","article-title":"Surfactant protein C expression in urethane-induced murine pulmonary tumors","volume":"156","author":"Mason","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0315","doi-asserted-by":"crossref","first-page":"4396s","DOI":"10.1158\/1078-0432.CCR-06-0414","article-title":"Mouse models of lung cancer","volume":"12","author":"Dutt","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcp.22719","article-title":"Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells","volume":"227","author":"Yu","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0325","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0330","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2012.11.025_bib0335","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/carcin\/bgm189","article-title":"2-Cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells","volume":"28","author":"Chintharlapalli","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.taap.2012.06.014","article-title":"A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4","volume":"263","author":"Min","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0345","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mc.20518","article-title":"Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative","volume":"48","author":"Jutooru","year":"2009","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.bcp.2012.11.025_bib0350","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2010.10.026","article-title":"Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells","volume":"650","author":"Youns","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0355","first-page":"5034","article-title":"Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0360","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1541-7786.MCR-10-0342","article-title":"NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway","volume":"8","author":"Wynne","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0365","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pros.20551","article-title":"Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells","volume":"67","author":"Chen","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2012.11.025_bib0370","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0530278100","article-title":"Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum","volume":"100","author":"Welsh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.11.025_bib0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1078-0432.CCR-05-1331","article-title":"Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis","volume":"12","author":"Brown","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0380","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1055-9965.EPI-06-0841","article-title":"Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases","volume":"16","author":"Selander","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2012.11.025_bib0385","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","article-title":"Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers","volume":"10","author":"Koopmann","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0390","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","article-title":"Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer","volume":"15","author":"Brown","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.11.025_bib0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/bi001064p","article-title":"Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities","volume":"40","author":"Fairlie","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2012.11.025_bib0400","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djh227","article-title":"H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer","volume":"96","author":"Lindmark","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2012.11.025_bib0405","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1055-9965.EPI-06-0063","article-title":"Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival","volume":"15","author":"Hayes","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2012.11.025_bib0410","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1158\/1055-9965.EPI-07-0165","article-title":"MIC1 and IL1RN genetic variation and advanced prostate cancer risk","volume":"16","author":"Cheng","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bcp.2012.11.025_bib0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2008.12.008","article-title":"Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers","volume":"401","author":"Baek","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2012.11.025_bib0420","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/carcin\/bgh199","article-title":"Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis","volume":"25","author":"Jang","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2012.11.025_bib0425","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2006.11.032","article-title":"Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt\/GSK3beta\/NAG-1 pathway","volume":"251","author":"Pang","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2012.11.025_bib0430","first-page":"1029","article-title":"Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene","volume":"40","author":"Wang","year":"2009","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.bcp.2012.11.025_bib0435","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1745-7254.2007.00652.x","article-title":"Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide","volume":"28","author":"Huang","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bcp.2012.11.025_bib0440","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bcp.2012.11.025_bib0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"Gonzalez-Perez","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0450","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/gast.2002.32972","article-title":"Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue","volume":"122","author":"Kim","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2012.11.025_bib0480","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1940-6207.CAPR-10-0196","article-title":"The role of NAG-1\/GDF15 in the inhibition of intestinal polyps in APC\/Min mice by sulindac","volume":"4","author":"Wang","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bcp.2012.11.025_bib0460","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/ijc.23302","article-title":"Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene","volume":"122","author":"Kim","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2012.11.025_bib0465","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2009.03.006","article-title":"A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2","volume":"282","author":"Iguchi","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2012.11.025_bib0470","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1535-7163.MCT-04-0201","article-title":"The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1\/MIC-1\/GDF-15","volume":"4","author":"Kim","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.11.025_bib0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1747-4949.2005.00016.x","article-title":"Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?","volume":"1","author":"Diener","year":"2006","journal-title":"Int J Stroke"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212007666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212007666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:21Z","timestamp":1777377561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212007666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0006295212007666"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.11.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1\/GDF15) in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2012.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}